Skip to content

Addiction: all studies

Page 405 of 855: studies 4,041 to 4,050 of 8,547, newest first. Back to the addiction overview

Research

Understanding the Mechanisms of Action and Effects of Drugs of Abuse.

Molecules June 24, 2023 Daniela-Mădălina Ciucă Anghel, Gabriela Viorela Nițescu, Andreea-Taisia Tiron et al. 69 citations

Drug abuse and addiction are major public health concerns, with millions of people worldwide affected by the negative consequences of drug use. To better understand this complex issue, a review was conducted to examine the mechanisms of action and effects of drugs of abuse, including their acute and chronic effects, the symptoms of abstinence syndrome, as well as their cardiovascular impacts....

An adversarial collaboration to critically evaluate theories of consciousness

bioRxiv Preprint Server June 23, 2023 Oscar Ferrante, Urszula Gorska-Klimowska, Simon Henin et al. preprint

Different theories explain how subjective experience arises from brain activity1,2. These theories have independently accrued evidence, yet, confirmation bias and dependence on design choices hamper progress in the field3. Here, we present an open science adversarial collaboration which directly juxtaposes Integrated Information Theory (IIT)4,5 and Global Neuronal Workspace Theory (GNWT)6–10,...

Digital Depersonalization

Feeling Unreal June 22, 2023 Daphne Simeon, Jeffrey Abugel

Abstract: The social isolation created by the COVID-19 lockdown prompted a dramatic increase in use of the internet, Zoom, and Skype. It also brought greater attention to the subject of internet addiction. New books and studies took a closer look at problematic internet use and issues related to increased time spent online, as well as increased dependence on smartphones for social interaction....

Methodological changes to improve retention: Results from two pediatric cognitive behavioral therapy studies.

Journal of Clinical Psychology June 22, 2023 Lisa DeMarni Cromer, Brooke A F Pangelinan, Elissar El Sabbagh et al.

Objective: Retention is challenging in clinical research with pediatric populations. The retention obstacles that are experienced in adult samples are compounded because child samples depend on caregiver support and engagement. The present paper describes retention improvements following protocol adaptations across a pair of cognitive behavioral pilot studies for nightmare sufferers aged 6-17....

Commentary: Not in the drug, not in the brain: causality in psychedelic experiences from an enactive perspective

Frontiers in Psychology June 22, 2023 Ignacio Cea 3 citations

Commentary on: Meling D and Scheidegger M (2023) Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective. Front. Psychol. 14:1100058. doi: 10.3389/fpsyg.2023.1100058 Word Count: 992 Figures and Tables: none We welcome with great enthusiasm Meling & Scheidegger (2023) (henceforth "M&S") timely contribution to advance an enactive approach to...

KLASIKINIŲ PSICHODELIKŲ VEIKIMO MECHANIZMAI, BIOLOGINĖS SAVYBĖS IR TERAPINĖ NAUDA PACIENTAMS, TURINTIEMS PSICHIKOS SUTRIKIMŲ

Health Sciences June 22, 2023 Rapolas Šalaševičius, Gabrielė Pakriaušytė

Klasikiniai psichodelikai – tai natūralios (psilocibi­nas) arba sintetinės (LSD) medžiagos, stimuliuojančios 5-HT2A receptorius ir sukeliančios pakitusias regos, klau­sos, kognityvines ar nuotaikos būsenas. Šios medžiagos vis dažniau patraukia mokslo tyrėjų bendruomenės dė­mesį dėl jų potencialios naudos pacientams, sergantiems įvairaus spektro psichikos sutrikimais. Atlikę literatūros apžvalgą...

Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data

Journal of Psychoactive Drugs June 22, 2023 Bheatrix Bienemann, Amanda Rocha Barbosa, Lucas Villar Magalhães da Cruz et al. 3 citations

There has been growth in the use of psychedelics by the global population in recent years. In addition to recreational and ritualistic use, recent research into psychedelics has brought advances for treating mental disorders. Understanding the specific circumstances in which psilocybin leads to positive outcomes may have important implications for the future of its clinical use and for harm...

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats

Frontiers in Neuroscience June 22, 2023 Filip Tylš, Čestmír Vejmola, Vlastimil Koudelka et al. 9 citations

Introduction Psilocybin is one of the most extensively studied psychedelic drugs with a broad therapeutic potential. Despite the fact that its psychoactivity is mainly attributed to the agonism at 5-HT 2A receptors, it has high binding affinity also to 5-HT 2C and 5-HT 1A receptors and indirectly modulates the dopaminergic system. Psilocybin and its active metabolite psilocin, as well as other...

Husserl, representationalism, and the theory of phenomenal intentionality

European Journal of Philosophy June 21, 2023 Chang Liu 4 citations

Abstract Representationalism is a philosophical position which reduces all phenomenal conscious states to intentional states. However, starting from the phenomenal consciousness, the phenomenal intentionality theory provides an explanation of all sorts of intentionality. Against Michael Shim's interpretation, I argue that, although Hussserl's phenomenology is certainly considered as an antipode...

Classics in Chemical Neuroscience: Dextromethorphan (DXM).

ACS Chemical Neuroscience June 21, 2023 Elliot W McClure, R Nathan Daniels

Dextromethorphan (DXM) was introduced in 1958 as the first non-opioid cough suppressant and is indicated for multiple psychiatric disorders. It has been the most used over-the-counter cough suppressant since its emergence. However, individuals quickly noticed an intoxicating and psychedelic effect if they ingested large doses. DXM's antagonism at N-methyl-d-aspartate receptors (NMDAr) is...

DOI: 10.1021/acschemneuro.3c00088 (opens in new tab) Full text (opens in new tab) Dextromethorphan Nmda receptor antagonist Cough Dextrorphan +2